CellSeed Inc logo

7776 - CellSeed Inc News Story

¥256 -3.0  -1.2%

Last Trade - 22/01/21

Sector
Healthcare
Size
Micro Cap
Market Cap £28.8m
Enterprise Value £20.8m
Revenue £1.05m
Position in Universe 3274th / 3891

TABLE-CellSeed - 9-MTH group results

Thu 12th November, 2020 7:30am
Nov 12 (Reuters)- 
             CellSeed Inc. 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended        Year to  
                Sep 30, 2020        Sep 30, 2019      Dec 31, 2020  
                   LATEST             YEAR-AGO           LATEST     
                   RESULTS             RESULTS          FORECAST    
  Sales            83 mln              210 mln           200 mln    
                 (-60.2 pct)         (-61.2 pct)       (-27.5 pct)  
  Operating     loss 602 mln        loss 554 mln      loss 742 mln  
  Recurring     loss 611 mln        loss 558 mln      loss 751 mln  
  Net           loss 611 mln        loss 557 mln      loss 781 mln  
  EPS          loss 44.09 yen      loss 48.55 yen    loss 56.36 yen 
  Ann Div                                NIL               NIL      
  -Q2 div            NIL                 NIL                        
  -Q4 div                                NIL               NIL      
  
  NOTE - CellSeed Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=7776.T
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.